Keyphrases
Functional Interaction
100%
Glycoprotein 130 (gp130)
100%
Biochemical Interactions
100%
Breast Cancer Cells
100%
EGF Receptor
100%
Oncostatin M
100%
Growth Factors
33%
Breast Cancer
33%
Estrogen Receptor-positive Breast Cancer
33%
ErbB2
33%
Signaling Pathway
16%
Mitogen-activated Protein Kinase
16%
Phosphorylation
16%
Cellular Differentiation
16%
Tyrosine Phosphorylation
16%
Cell Signaling
16%
PD98059
16%
Inhibitory Effect
16%
Mitogen
16%
Co-immunoprecipitation (co-IP)
16%
Insulin-like Growth factor-1
16%
Interleukin-6
16%
Synergism
16%
Induced Differentiation
16%
Tyrosine Kinase Receptor
16%
Proliferation Inhibition
16%
Breast Cells
16%
Cancer Pathogenesis
16%
Biological Effects
16%
Signal Diversity
16%
Heregulin
16%
MEK Inhibitor (MEKi)
16%
Signaling Receptor
16%
Inhibits Proliferation
16%
ErbB
16%
ErbB3
16%
Medicine and Dentistry
Receptor Family
100%
Cancer Cell
100%
Breast Cancer
100%
Epidermal Growth Factor Receptor
100%
Glycoprotein Gp 130
100%
Oncostatin M
100%
ErbB
66%
Receptor
33%
Growth Factor
33%
Cytokine
16%
Cell Differentiation
16%
Mitogenic Agent
16%
Protein Phosphorylation
16%
Estrogen Receptor Positive Breast Cancer
16%
Estrogen Receptor Negative Breast Cancer
16%
Interleukin 6
16%
2 (2 Amino 3 Methoxyphenyl)chromone
16%
Breast Cell
16%
Immunoprecipitation
16%
Neu Differentiation Factor
16%
Tyrosine Kinase Receptor
16%
extracellular signal regulated kinase
16%
MEK Inhibitor
16%
Platelet Derived Growth Factor
16%
Cell Signaling Pathway
16%
Biological Activity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Epidermal Growth Factor Receptor
100%
Oncostatin M
100%
Glycoprotein Gp 130
100%
Receptor
33%
Growth Factor
33%
Cytokine
16%
Mitogen Activated Protein Kinase
16%
2 (2 Amino 3 Methoxyphenyl)chromone
16%
Immunoprecipitation
16%
Interleukin 6
16%
Tyrosine Kinase Receptor
16%
Estrogen Receptor Negative Breast Cancer
16%
Neu Differentiation Factor
16%
Estrogen Receptor Positive Breast Cancer
16%
Synergism
16%
Mitogen Activated Protein Kinase Kinase Inhibitor
16%
Platelet Derived Growth Factor
16%
Mitogenic Agent
16%
Neuroscience
Epidermal Growth Factor Receptor
100%
Glycoprotein Gp 130
100%
Oncostatin M
100%
ErbB
66%
Receptor
33%
Growth Factor
33%
Protein Phosphorylation
16%
extracellular signal regulated kinase
16%
Immunoprecipitation
16%
Interleukin 6
16%
Estrogen Receptor
16%
Tyrosine Kinase Receptor
16%
STAT3
16%
Platelet-Derived Growth Factor
16%
Cellular Differentiation
16%
Neu Differentiation Factor
16%
MEK Inhibitor
16%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Epidermal Growth Factor Receptor
100%
Oncostatin M
100%
ErbB
66%
Growth Factor
33%
Cytokine
16%
Cellular Differentiation
16%
Tyrosine Phosphorylation
16%
extracellular signal regulated kinase
16%
Immunoprecipitation
16%
Interleukin 6
16%
Estrogen Receptor
16%
Tyrosine Kinase Receptor
16%
MEK Inhibitor
16%
STAT3
16%
Platelet-Derived Growth Factor
16%
Biological Activity
16%
Immunology and Microbiology
Cancer Cell
100%
Oncostatin M
100%
Glycoprotein Gp 130
100%
Growth Factor
33%
Cytokine
16%
Cell Differentiation
16%
Protein Phosphorylation
16%
Mitogen
16%
Interleukin 6
16%
Synergism
16%
Immunoprecipitation
16%
Platelet Derived Growth Factor
16%
Breast Cell
16%
STAT3
16%
Neu Differentiation Factor
16%
Biological Activity
16%
Tyrosine
16%